| First Posted | New Trial Filing | Phase | Status |
|---|---|---|---|
| 2026-05-19 | NCT07596849 A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants… | Phase 3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06909214 | A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With… | New Onset Generalized Myasthenia Gravis (gMG) | Recruiting |
| Phase 3 | |||
| NCT04812925 | A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in… | Primary Immune Thrombocytopenia | Active, Not Recruiting |
| NCT06684847 | A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's… | Primary Sjogrens Disease | Active, Not Recruiting |
| NCT07570316 | A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants… | Graves' Disease | Not Yet Recruiting |
| NCT07596849 | A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants… | Graves Disease | Not Yet Recruiting |
| NCT05979441 | A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of… | Myositis | Enrolling by Invitation |
| Phase 2/3 | |||
| NCT06392386 | A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With… | Generalized Myasthenia Gravis | Recruiting |
| Not specified | |||
| NCT07264426 | Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study | Chronic Inflammatory Demyelinating Polyradiculoneuropathy | Recruiting |